Nathanael Fillmore, PhD

Adjunct Instructor, Medicine

Nathanael Fillmore
617.638.7012
72 E. Concord Street

Biography

I lead a group at the VA Boston Healthcare System and Harvard Medical School that uses VA clinical, genomic, and imaging data, together with machine learning and statistical methods, in research to improve patient care. We are also working on software and methodological improvements to support these efforts.

Education

  • University of Wisconsin Madison, PhD
  • University of Wisconsin Madison, MS
  • Carleton College, BA

Publications

  • Published on 3/14/2024

    Jacobs T, Jacobson SR, Fortea J, Berger JS, Vedvyas A, Marsh K, He T, Gutierrez-Jimenez E, Fillmore NR, Bubu OM, Gonzalez M, Figueredo L, Gaggi NL, Plaska CR, Pomara N, Blessing E, Betensky R, Rusinek H, Zetterberg H, Blennow K, Glodzik L, Wisniewski TM, Leon MJ, Osorio RS, Ramos-Cejudo J. The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people. Res Sq. 2024 Mar 14. PMID: 38559231.

    Read at: PubMed
  • Published on 2/5/2024

    Anand ST, Vo AD, La J, Do NV, Fillmore NR, Brophy M, Branch-Elliman W, Monach PA. Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration. JAMA Netw Open. 2024 Feb 05; 7(2):e240288. PMID: 38393725.

    Read at: PubMed
  • Published on 2/2/2024

    Bihn JR, Cioffi G, Waite KA, Kruchko C, Neff C, Price M, Ostrom QT, Swinnerton KN, Elbers DC, Mooney MA, Rachlin J, Stein TD, Brophy MT, Do NV, Ferguson RE, Priemer DS, Perl DP, Hickman RA, Nabors B, Rusiecki J, Barnholtz-Sloan JS, Fillmore NR. Brain tumors in United States military veterans. Neuro Oncol. 2024 Feb 02; 26(2):387-396. PMID: 37738677.

    Read at: PubMed
  • Published on 1/25/2024

    Do NV, Elbers DC, Fillmore NR, Ajjarapu S, Bergstrom SJ, Bihn J, Corrigan JK, Dhond R, Dipietro S, Dolgin A, Feldman TC, Goryachev SD, Huhmann LB, La J, Marcantonio PA, McGrath KM, Miller SJ, Nguyen VQ, Schneeloch GR, Sung FC, Swinnerton KN, Tarren AH, Tosi HM, Valley D, Vo AD, Yildirim C, Zheng C, Zwolinski R, Sarosy GA, Loose D, Shannon C, Brophy MT. Matching Patients to Accelerate Clinical Trials (MPACT): Enabling Technology for Oncology Clinical Trial Workflow. Stud Health Technol Inform. 2024 Jan 25; 310:1086-1090. PMID: 38269982.

    Read at: PubMed
  • Published on 1/25/2024

    Clark M, Meyer C, Ramos-Cejudo J, Elbers DC, Pierce-Murray K, Fricks R, Alterovitz G, Rao L, Brophy MT, Do NV, Grossman RL, Fillmore NR. Transfer Learning for Mortality Prediction in Non-Small Cell Lung Cancer with Low-Resolution Histopathology Slide Snapshots. Stud Health Technol Inform. 2024 Jan 25; 310:735-739. PMID: 38269906.

    Read at: PubMed
  • Published on 1/25/2024

    Elbers DC, Fillmore NR, La J, Tosi HM, Ajjarapu S, Dhond R, Murray K, Valley D, Shannon C, Brophy MT, Do NV. Building Research Infrastructure to Develop Greater Learning Efficiencies (BRIDGE). Stud Health Technol Inform. 2024 Jan 25; 310:1131-1135. PMID: 38269991.

    Read at: PubMed
  • Published on 1/25/2024

    Monach PA, Anand ST, Fillmore NR, La J, Branch-Elliman W. Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans Health Administration, March-September 2022. MMWR Morb Mortal Wkly Rep. 2024 Jan 25; 73(3):57-61. PMID: 38271286.

    Read at: PubMed
  • Published on 1/10/2024

    Hernandez KM, Venkat A, Elbers DC, Bihn JR, Brophy MT, Do NV, La J, Liu Q, Prokhorenkov A, Metoki-Shlubsky N, Sung FC, Paller CJ, Fillmore NR, Grossman RL. Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons. Cold Spring Harb Mol Case Stud. 2023 Dec; 9(4). PMID: 38050021.

    Read at: PubMed
  • Published on 11/15/2023

    Anand ST, Vo AD, La J, Brophy M, Do NV, Fillmore NR, Branch-Elliman W, Monach PA. Risk of severe coronavirus disease 2019 despite vaccination in patients requiring treatment with immune-suppressive drugs: A nationwide cohort study of US Veterans. Transpl Infect Dis. 2024 Feb; 26(1):e14168. PMID: 37966134.

    Read at: PubMed
  • Published on 11/14/2023

    Fillmore NR, La J, Wu JT, Corrigan JK, Branch-Elliman W, Monach P, Brophy MT, Do NV, Munshi NC. Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders. Blood Adv. 2023 Nov 14; 7(21):6767-6770. PMID: 37647600.

    Read at: PubMed

View 56 more publications: View full profile at BUMC

View all profiles